Solar PPA for chemicals & pharmaceuticals

2026 indicative PPA profile

Typical system size	400kWp-1.5MWp
Year-1 tariff	11-14 p/kWh
Year-1 saving	£60k-£260k
Parent sector	Factories & Manufacturing

Cleanrooms never switch off

The defining electrical feature of chemicals and pharmaceutical manufacturing is the cleanroom. Its HVAC, filtration, humidity control and positive-pressure air handling must run continuously to hold classification, whether or not a batch is in progress. Add reactors, dryers, process chillers and pumps and you have a high, flat base load — one of the best self-consumption profiles anywhere in the factory sector, because generated solar is absorbed on site around the clock rather than spilled to the grid at a fraction of its value.

Disclosure, not the electricity bill, is usually the trigger

In this sub-sector the lead driver is rarely the tariff alone. ESG and Scope 2 disclosure obligations do most of the pushing, and many tier-1 pharmaceutical customers now require their own suppliers to report Scope 2 emissions — which turns a metered, on-site renewable supply from a nice-to-have into a commercial necessity. A power purchase agreement delivers that renewable supply without diverting capital from plant, validation or R&D, and it produces the audit-ready generation data the disclosure regime demands.

Scale, tariff and what to check

Arrays here commonly run 400 kWp to 1.5 MWp, with PPA rates of 11 to 14 p/kWh and savings of £60,000 to £260,000 a year. Before signing, weigh a few things specific to a regulated site:

• GMP and validation controls mean roof and electrical works need careful change-control sign-off
• Standby generation and UPS coverage should be reviewed alongside the array so resilience is never compromised
• Ask each developer how their contract reports emissions for disclosure — the provider comparison is a good place to start

From there, the pricing explainer shows how a steady cleanroom load earns a competitive unit rate.